New DNA mapping technique may solve mystery birth defects
NCT ID NCT07370792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new genetic technique called optical genome mapping (OGM) to find hidden DNA changes in children with multiple birth defects and intellectual disability. Standard genetic tests have already failed to find a cause for these children. Researchers will collect a blood sample from 55 participants and use OGM to look for structural variants that other methods miss. If it works, OGM could become a routine diagnostic tool to give families answers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
blood sample for optical genome mapping
What this could lead to
If successful, this could improve genetic diagnosis for children with multiple birth defects, helping families get answers and better medical management.
What could go wrong
This is a small, early-stage study with only 55 participants. The technique may not find new genetic causes, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••